TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
42.86
-0.17 (-0.40%)
At close: May 8, 2026, 4:00 PM EDT
43.23
+0.37 (0.85%)
After-hours: May 8, 2026, 7:58 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Product Revenue, Net
688.58M606.93M313.73M
Product Revenue, Net Growth
13.45%93.46%240.99%
License Revenue
-152.00K152.00K
License Revenue Growth
---99.89%
Milestone Revenue
--12.50M
Royalty Revenue
-5.62M801.00K
Royalty Revenue Growth
-601.00%-
Other Revenue
-3.59M1.82M
Other Revenue Growth
-97.04%21.21%
Total License, Milestone, Royalty and Other Revenue
11.77M9.36M15.28M
Total License, Milestone, Royalty and Other Revenue Growth
25.74%-38.73%-89.22%
Revenue (Other)
--9.21M-15.12M
Revenue (Total)
700.35M616.29M329.00M
Revenue (Total) Growth
13.64%87.32%40.80%
Updated May 6, 2026. Data Source: Fiscal.ai.